EUTM file information
018502709
DBITE
June 28, 2021
Trademark Summary
The trademark application DBITE was filed by Amgen Research (Munich) GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on September 1, 2021, and it was registered by office on December 9, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
A transfer of the trademark registration was recorded on March 31, 2022.
Goods And Services
- The mark was filed in class 5 with Medicaments, namely polypeptides, for use in the treatment of tumorous diseases, cancer, allergies, autoimmunity, inflammation, osteoporosis, graft versus host diseases, transplant rejection, cardiovascular diseases, metabolic diseases, neurological diseases, and minimal residual diseases.
- The mark was filed in class 9 with Downloadable educational materials on therapeutic polypeptides and use thereof.
- The mark was filed in class 16 with Printed educational materials on therapeutic polypeptides and use thereof and printed educational materials in the field of therapeutic polypeptides and use thereof..
- The mark was filed in class 35 with Promoting interest and awareness among healthcare practitioners and the public regarding therapeutic polypeptides and use thereof and promoting education for healthcare professionals on health and medical issues, namely, therapeutic polypeptides and use thereof..
- The mark was filed in class 42 with following description of goods:
- Providing medical and scientific research information regarding therapeutic polypeptides and use thereof
- Providing a website in relation to medical and scientific research information regarding antibody derivatives and use thereof
- Providing scientific information regarding antibody derivatives and use thereof
- Providing a website in relation to scientific information regarding antibody derivatives and use thereof.
- The mark was filed in class 44 with Providing medical information regarding therapeutic polypeptides and use thereof and providing a website in relation to medical information regarding antibody derivatives and use thereof..
